Lower Incidence of Parkinson’s Disease in Patients with Metabolic Syndrome or any of its Components: A Longitudinal Study
Objective: To examine the association between incident Parkinson’s disease (PD) and metabolic syndrome (MetS) in a retrospective population study for an extensive period before diagnosis.…Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study
Objective: To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…Muscle co-contraction in people with Parkinson’s disease suffering from freezing of gait
Objective: 1) to test the feasibility of using novel, disposable EMG electrodes to study co-contraction (CC) and 2), to test if muscle CC is higher…Initiating a Hybrid-Modality International Movement Disorders Fellowship: A Collaborative Effort Among Latin American Countries
Objective: To describe a hibrid modality with high-quality, well-structured and overseeded education program. Background: In the field of movement disorders, specialized centers have emerged as…Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry
Objective: To determine the frequency of hypertension (HBP) and type 2 diabetes mellitus (T2DM) as comorbidities in the Nigerian PD Research network (NPDR) cohort, and…α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease
Objective: To examine the relationship between the reaction parameters of the cerebrospinal fluid (CSF) αSyn seed amplification assay (αSyn-SAA) to the risk of developing motor…Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study
Objective: To explore the role of cholinergic dysfunction in dyskinesia symptoms in people with Parkinson’s disease (PD). Background: Dyskinesias, involuntary and sometimes excessive or uncontrolled…Parkinson Disease. An innovative Aproach
Objective: Aims: promoting maximum autonomy, potentiating resources, improve functionality, stimulating activity, preventing complications. Background: Since 2006, the Program has operated uninterruptedly, even during COVID-19. Aimed…Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards
Objective: The Parkinson’s Foundation made another significant step toward its vision to eliminate preventable harm and promote higher reliability in care with the launch of…SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients
Objective: Use a news automated, motor-controlled cognitive battery, the SelfCog®, to compare cognitive deficits in PD patients. Background: Mild cognitive impairment (MCI) is a major…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 338
- Next Page »